AN2 Therapeutics, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ANTX | 2137.HK | BBOT | ACRS | BHVN | VERU | |
|---|---|---|---|---|---|---|
| Market cap | 160.38M | 739.58M | 184.40M | 570.34M | 2.30B | 37.51M |
| P/E (TTM) | — | — | — | — | — | — |
| Forward P/E | -5.3 | -2.0 | -0.8 | -5.1 | -8.2 | -2.2 |
| Price/book | 2.0 | 0.3 | 0.6 | 4.1 | -23.4 | 1.3 |
| Dividend yield | — | — | — | — | — | — |
| 1-year change | +279.46% | −44.59% | −81.22% | +62.11% | +78.66% | −15.63% |
| Today | +1.67% | 0.00% | −0.86% | −1.60% | −2.37% | +1.85% |
The closest companies by business and industry (Biotechnology). Prices may be delayed up to 15 min.
Latest news
All ANTX news ›SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of AN2 Therapeutics, Inc. (NASDAQ: ANTX)
NEW YORK, Oct. 12, 2026 /PRNewswire/ -- Purcell & Lefkowitz LLP announces that it is investigating AN2 Therapeutics, Inc. (NASDAQ: ANTX) on behalf of the company's shareholders. The investigation ... SHAREHOLDER ALERT: Purcell & Lefkowitz…
AN2 Therapeutics to Present Phase 2 Design for Epetraborole in Polycythemia Vera at the 18th International Congress on Myeloproliferative Neoplasms
FinancialContent - AN2 Therapeutics to Present Phase 2 Design for Epetraborole in Polycythemia Vera at the 18th International Congress on Myeloproliferative Neoplasms FinancialContent (Nasdaq: ANTX), a clinical stage biopharmaceutical…
AN2 Therapeutics to Participate at Upcoming November 2026 Investor Conferences
BioSpace AN2 Therapeutics to Participate at Upcoming November 2026 Investor Conferences MENLO PARK, Calif.--(BUSINESS WIRE)--AN2 Therapeutics, Inc. (NASDAQ: ANTX), a clinical stage biopharmaceutical company discovering a
More from 1 other outlet
AN2 Therapeutics Director Patricia A. Martin Acquires 389 Shares at No Cost
Can Record Bullion Prices Keep Energizing Kinross Gold (NYSE:KGC)? What Did Citigroup (NYSE:C) Report as Bank Results Season Opened? Can Wells Fargo (NYSE:WFC) Shine After Its Asset Cap Removal? On October 13, 2026, director Patricia A.…
Total cash dividends paid of AN2 Therapeutics, Inc. – NASDAQ:ANTX
TradingView Total cash dividends paid of AN2 Therapeutics, Inc.
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Most coverage from
- biospace.com1
- kalkinemedia.com1
- markets.financialcontent.com1
- morningstar.com1
- natlawreview.com1
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 7 articles, not a forecast.